CEO Chaejung Heo Receives Merck '350 Future Researcher Award'

Recognized for achievements in molecular and cellular biology, CEO Chaejung Heo was awarded the Merck 350 Future Researcher Award on October 7, 2026.

Merck Future Researcher Award for CEO Heo. Learn about haddscience. @haddscience
chapter 01. 350 Future Researcher Award 🏆. HADD Science CEO Chaejung Heo has received Merck's '350 Future Researcher Award'.
chapter 02. ICKSMCB 2026 🧬. The award ceremony was held at the International Conference of the Korean Society for Molecular and Cellular Biology, taking place at Daejeon Convention Center (DCC) from October 5 to 8, 2026.
chapter 03. Award Lecture 🎤. CEO Chaejung Heo gave a talk in the ‘Merck 350 Future Researcher Award Lectures’ session.
chapter 04. Achievements in Molecular & Cellular Biology 🔬. This award is presented to researchers with outstanding achievements in molecular and cellular biology. The presentation took place on October 7, 2026.
chapter 05. Commemorating the Award 📸. CEO Chaejung Heo received this award as a researcher affiliated with Sungkyunkwan University.
HADD SCIENCE. From Research to the Field 🧫. HADD Science will continue to create biomaterials essential for research fields based on organoid and 3D cell culture research.